BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

The clinical trial aims to evaluate three of RVAC's COVID-19 vaccine candidates that include one against the ancestral strain, one against an Omicron strai...

February 21, 2023 | News

"Fueling Growth and Innovation: The Rise of Biotech Investment in the Asia Pacific Region"

According to a report by Deloitte, the APAC biotech market is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2020 and 2025, with...

February 20, 2023 | News

Global Sarcoma Therapy Now Approved for New Zealand Patients

Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe for New Zealand patients YONDELIS® (trabectedin) demonstra...

February 18, 2023 | News

Oxford Nanopore Technologies teams up with UPS Healthcare to accelerate delivery of next-generation DNA sequencing technology

Oxford Nanopore Technologies today announced an extension of its collaboration with UPS Healthcare to accelerate the delivery of Oxford Nanopore DNA/RNA se...

February 16, 2023 | News

Inventia Life Science collaborates with MSD to develop 3D advanced cell models

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...

February 16, 2023 | News

Vir Biotechnology Announces Amended Collaboration Agreement with GSK

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the research collaboration agreement established with GSK in 2020 has been amended to reflect th...

February 14, 2023 | News

HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities

HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders Interon is deve...

February 13, 2023 | News

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences...

February 09, 2023 | News

Microba and BioAgilytix announce partnership to fast-track therapeutic delivery

Enables innovators to confidently leverage microbiome endpoints in clinical trials Delivers superior outcomes for clients at each stage of the d...

February 09, 2023 | News

SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center

The additional investment for the ‘R&PD Center’ was confirmed by the board of directors committee with a total of 261 million USD SK bio...

February 08, 2023 | News

Parse Biosciences Announces Evercode TCR and Gene Capture

Parse Biosciences, a leading provider of accessible and scalable single-cell sequencing solutions, today announced the availability of Evercode&trade...

February 08, 2023 | News

NGeneBio launched NGS based breast cancer diagnostic service in Thailand

Launched NGS based breast cancer diagnostic service in a newly installed inspection laboratory of a Thai consignment inspection agency, MP Group. &n...

February 06, 2023 | News

Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change

PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for spec...

February 03, 2023 | News

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...

February 01, 2023 | News

Stay Connected